CIK 0001829802 · <br>Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-01 | Krebs Stephanie Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-09-11 | Celebi John President and CEO | Purchase | +500 | $0.85 | $425 | 111,311 |
| 2023-07-31 | Cambrian BioPharma Inc 10% owner | Returned to the company | −1,587,302 | $1.26 | $2.0M | 3,653,120 |
| 2023-07-31 | Peyer James Director | Returned to the company | −1,587,302 | $1.26 | $2.0M | 3,653,120 |
| 2023-07-10 | RINGO WILLIAM R Director | Grant or award | +4,466 | 23,399 | ||
| 2023-07-10 | RINGO WILLIAM R Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | RICKS THOMAS G Director | Grant or award | +4,466 | 8,932 | ||
| 2023-07-10 | RICKS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | Broder Samuel Director | Grant or award | +4,466 | 8,932 | ||
| 2023-07-10 | Broder Samuel Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | Humer Kristian Director | Grant or award | +4,466 | 8,932 | ||
| 2023-07-10 | Humer Kristian Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | English Jessie Director | Grant or award | +4,466 | 8,932 | ||
| 2023-07-10 | English Jessie Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | Vojta Deneen Director | Grant or award | +4,466 | 8,932 | ||
| 2023-07-10 | Vojta Deneen Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | Holmen Bob Director | Grant or award | +4,466 | 25,598 | ||
| 2023-07-10 | Holmen Bob Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 | ||
| 2023-07-10 | Peyer James Director | Grant or award | +4,466 | 5,240,422 | ||
| 2023-07-10 | Peyer James Director | Grant or award · Stock Option (Right to Buy) | +14,550 | 14,550 |
Page 9 of 12 · 238 trades